| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 670 | $80 | $56.3K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 190 | $170 | $31.8K |
| J3490 | Unclassified drugs | 40 | $560 | $20.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 290 | $60 | $17.7K |
| 0421T | N/A | 20 | $650 | $15.7K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 80 | $140 | $10.7K |
| J9030 | BCG live intravesical instillation, 1 mg | 4,550 | $1 | $9.1K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 50 | $110 | $5.7K |
| 51720 | This is a common treatment for bladder cancer. It involves instilling an anticarcinogenic agent into the bladder through a catheter. The provider leaves the agent in the bladder for a period of time… | 90 | $70 | $5.6K |
| 84153 | The lab analyst performs testing for total prostate specific antigen, PSA, typically on serum or plasma samples using laboratory analyzers. PSA is a protein the prostate gland produces, and… | 230 | $20 | $4.1K |